Clinical Trial Update: Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD [Phase 4]

View source ↗

Summary

Phase 4 trial assessing diuretics in chronic kidney disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: VA Office of Research and Development | Conditions: Chronic Kidney Disease | Phase 4 | Status: WITHDRAWN